Detalhe da pesquisa
1.
Phase 1b Trial Evaluating Tolerability and Activity of Targeted Fibroblast Growth Factor Receptor Inhibition in Localized Upper Tract Urothelial Carcinoma.
J Urol
; : 101097JU0000000000003928, 2024 Apr 10.
Artigo
Inglês
| MEDLINE | ID: mdl-38573872